Amerigo Allegretto[email protected]Womens ImagingPandemic tied to breast biopsy delaysCompared with the pre-COVID-19 period, women are more likely now to face delays in image-guided breast biopsy.May 15, 2025ISMRM 2025ISMRM: Adding dobutamine stress imaging to CMR feasibleAdding dobutamine stress imaging during clinical cardiovascular MR exams is feasible for separating athletic hearts from hearts with early DCM.May 14, 2025ISMRM 2025ISMRM: Diffusion MRI predicts progression to Alzheimer'sA presentation at ISMRM 2025 suggests diffusion MRI could predict progression from mild cognitive impairment to Alzheimer's.May 11, 2025VideosPhilips highlights imaging informatics for improving rad workforcePhilipsMay 8, 2025Womens ImagingAbout half of women undecided on AI's use in breast imagingThe jury is out on AI use in breast imaging, but women with a higher education and more health literacy are more likely to welcome it.May 7, 2025Womens ImagingUltrafast breast MRI's advantages may need to be reconsideredUltrafast MRI fell short of expectations when compared to DCE-MRI in terms of lesion conspicuity and classification.May 6, 2025UltrasoundARRS: Cancer status should be considered for axillary breast ultrasoundResearch shown at ARRS 2025 found that breast cancer status and exam indication should be considered when reading axillary ultrasound exams.May 5, 2025Womens ImagingARRS: Get involved with breast health advocacyAt ARRS 2025, Amy Patel, MD, discussed the need for advocacy to drive legislation on insurance coverage for women with dense breasts.May 2, 2025Womens ImagingARRS: Most women under 40 have no imaging before breast cancer diagnosisMost young women who are diagnosed with breast cancer had no prior imaging performed.May 1, 2025Womens ImagingMultidisciplinary breast cancer care improves time-to-treatmentMultidisciplinary breast cancer care improves time-to-treatment at safety net hospitals.May 1, 2025Page 1 of 56Next PageTop StoriesISMRM 2025ISMRM: 4D flow MRI shows promise in chronic liver disease4D flow MRI could help identify fibrosis in patients with chronic liver disease, a study suggests.ISMRM 2025ISMRM: Low-field MR elastography feasible in liver imagingISMRM 2025ISMRM: 7-tesla MRI illuminates the roots of fatigue in depressed individualsCTClinical demand drives innovation in CT equipment marketISMRM 2025Video from ISMRM: Kate Hanneman on MRI equipment sustainability
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
